ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.35
+2.17% today
Updated 2026-04-30
Market cap
$307.45M
P/E ratio
15.93
P/S ratio
0.55x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$2 – $7
Volume
1.4M
Organogenesis Holdings Inc (ORGO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
6.56%
Operating margin
28.90%
ROE
9.04%
ROA
6.43%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2001 | $1.04M | $-2.88M | -14.71% | -245.98% | -276.55% |
| 2015 | $98.97M | $-25160.00 | 53.07% | -0.03% | -0.03% |
| 2016 | $0.00 | $-208698.00 | — | — | — |
| 2017 | $0.00 | $-2.09M | — | — | — |
| 2018 | $193.45M | $-64.83M | 64.43% | -26.65% | -33.51% |
| 2019 | $260.98M | $-38.71M | 70.90% | -11.44% | -14.83% |
| 2020 | $338.30M | $17.23M | 74.19% | 7.89% | 5.09% |
| 2021 | $467.36M | $94.20M | 75.57% | 15.45% | 20.16% |
| 2022 | $450.89M | $15.53M | 76.71% | 4.95% | 3.44% |
| 2023 | $433.14M | $4.95M | 75.42% | 2.89% | 1.14% |
| 2024 | $482.04M | $861000.00 | 75.99% | -0.27% | 0.18% |
| 2025 | $564.17M | $37.03M | 73.57% | 9.99% | 6.56% |